DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis

Nature Communications

Volumn 6, Issue , 2015, Pages

  Pathania, Rajneesh ^a   Ramachandran, Sabarish ^a   Elangovan, Selvakumar ^a   Padia, Ravi ^a   Yang, Pengyi ^b   Cinghu, Senthilkumar ^b   Veeranan Karmegam, Rajalakshmi ^a   Arjunan, Pachiappan ^a   Gnana Prakasam, Jaya P ^a   Sadanand, Fulzele ^a   Pei, Lirong ^a   Chang, Chang Sheng ^a   Choi, Jeong Hyeon ^a   Shi, Huidong ^a   Manicassamy, Santhakumar ^a   Prasad, Puttur D ^a   Sharma, Suash ^a   Ganapathy, Vadivel ^a   Jothi, Raja ^b   Thangaraju, Muthusamy ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 1; ISL1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; INSULIN GENE ENHANCER BINDING PROTEIN ISL-1; LIM HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR;

CANCER; DNA; EMBRYO; GENE EXPRESSION; GERM CELL; TUMOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CELL; BREAST TUMOR; CANCER INCIDENCE; CANCER STEM CELL; CARCINOGENESIS; CELL POPULATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAMMARY GLAND; MAMMARY STEM CELL; METHYLATION; MOUSE; NONHUMAN; OVERALL SURVIVAL; PROTEIN EXPRESSION; STEM CELL; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; ANIMAL; CELL LINE; CYTOLOGY; EXPERIMENTAL MAMMARY NEOPLASM; FLUORESCENCE MICROSCOPY; GENETICS; GROWTH, DEVELOPMENT AND AGING; MCF-7 CELL LINE; METABOLISM; TUMOR CELL LINE; UDDER; WESTERN BLOTTING;

MUS;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOGENESIS; CELL LINE; CELL LINE, TUMOR; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOWN-REGULATION; FEMALE; HUMANS; LIM-HOMEODOMAIN PROTEINS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MCF-7 CELLS; MICE; MICROSCOPY, FLUORESCENCE; NEOPLASTIC STEM CELLS; STEM CELLS; TRANSCRIPTION FACTORS;

EID: 84928799024     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7910     Document Type: Article

References (44)

1. Stingl, J. et al. Purification and unique properties of mammary epithelial stem cells. Nature 439, 993-997 (2006).
2. Stingl, J., Raouf, A., Emerman, J. T. & Eaves, C. J. Epithelial progenitors in the normal human mammary gland. J. Mammary Gland Biol. Neoplasia 10, 49-59 (2005).
3. Visvader, J. E. & Stingl, J. Mammary stem cells and the differentiation hierarchy: current status and perspectives. Genes Dev. 28, 1143-1158 (2014).
4. Rios, A. C., Fu, N. Y., Lindeman, G. J. & Visvader, J. E. In situ identification of bipotent stem cells in the mammary gland. Nature 506, 322-327 (2014).
5. Asselin-Labat, M. L. et al. Control of mammary stem cell function by steroid hormone signalling. Nature 465, 798-802 (2010).
6. Huang, T. H. & Esteller, M. Chromatin remodeling in mammary gland differentiation and breast tumorigenesis. Cold Spring Harb. Perspect. Biol. 2, a004515 (2010).
7. Pal, B. et al. Global changes in the mammary epigenome are induced by hormonal cues and coordinated by Ezh2. Cell Rep. 3, 411-426 (2013).
8. Smith, Z. D. & Meissner, A. DNA methylation: roles in mammalian development. Nat. Rev. Genet. 14, 204-220 (2013).
9. Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6-21 (2002).
10. Okano, M., Bell, D. W., Haber, D. A. & Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247-257 (1999).
11. Li, E., Bestor, T. H. & Jaenisch, R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915-926 (1992).
12. Tsumura, A. et al. Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b. Genes Cells 11, 805-814 (2006).
13. Robertson, K. D. DNA methylation and human disease. Nat. Rev. Genet. 6, 597-610 (2005).
14. Costello, J. F. et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet. 24, 132-138 (2000).
15. Chan, A. O. et al. CpG island methylation in aberrant crypt foci of the colorectum. Am. J. Pathol. 160, 1823-1830 (2002).
16. Laird, P. W. The power and the promise of DNA methylation markers. Nat. Rev. Cancer 3, 253-266 (2003).
17. Trowbridge, J. J., Snow, J. W., Kim, J. & Orkin, S. H. DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells. Cell Stem Cell 5, 442-449 (2009).
18. Sen, G. L., Reuter, J. A., Webster, D. E., Zhu, L. & Khavari, P. A. DNMT1 maintains progenitor function in self-renewing somatic tissue. Nature 463, 563-567 (2010).
19. Tsai, C. C., Su, P. F., Huang, Y. F., Yew, T. L. & Hung, S. C. Oct4 and Nanog directly regulate Dnmt1 to maintain self-renewal and undifferentiated state in mesenchymal stem cells. Mol. Cell 47, 169-182 (2012).
20. Trowbridge, J. J. et al. Haploinsufficiency of Dnmt1 impairs leukemia stem cell function through derepression of bivalent chromatin domains. Genes Dev. 26, 344-349 (2012).
21. Gay, F., Anglade, I., Gong, Z. & Salbert, G. The LIM/homeodomain protein islet-1 modulates estrogen receptor functions. Mol. Endocrinol. 14, 1627-1648 (2000).
22. Broske, A. M. et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat. Genet. 41, 1207-1215 (2009).
23. Tadokoro, Y., Ema, H., Okano, M., Li, E. & Nakauchi, H. De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hematopoietic stem cells. J. Exp. Med. 204, 715-722 (2007).
24. Feinberg, A. P., Ohlsson, R. & Henikoff, S. The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 7, 21-33 (2006).
25. Baylin, S. B. et al. Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells 3, 383-390 (1991).
26. Laird, P. W. & Jaenisch, R. DNA methylation and cancer. Hum. Mol. Genet. 3 Spec No, 1487-1495 (1994).
27. Eden, A., Gaudet, F., Waghmare, A. & Jaenisch, R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300, 455 (2003).
28. Herschkowitz, J. I. et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 8, R76 (2007).
29. Maroulakou, I. G., Anver, M., Garrett, L. & Green, J. E. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc. Natl Acad. Sci. USA 91, 11236-11240 (1994).
30. Zhang, W. et al. A NIK-IKKalpha module expands ErbB2-induced tumorinitiating cells by stimulating nuclear export of p27/Kip1. Cancer Cell 23, 647-659 (2013).
31. Gu, H. et al. Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling. Nat. Protoc. 6, 468-481 (2011).
32. Meissner, A. et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454, 766-770 (2008).
33. Voigt, P., Tee, W. W. & Reinberg, D. A double take on bivalent promoters. Genes Dev. 27, 1318-1338 (2013).
34. Jonsson, M., Dejmek, J., Bendahl, P. O. & Andersson, T. Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res. 62, 409-416 (2002).
35. Roose, J. et al. Synergy between tumor suppressor APC and the beta-catenin- Tcf4 target Tcf1. Science 285, 1923-1926 (1999).
36. Latini, F. R. et al. ABI3 ectopic expression reduces in vitro and in vivo cell growth properties while inducing senescence. BMC Cancer 11, 11 (2011).
37. Pfaff, S. L., Mendelsohn, M., Stewart, C. L., Edlund, T. & Jessell, T. M. Requirement for LIM homeobox gene Isl1 in motor neuron generation reveals a motor neuron-dependent step in interneuron differentiation. Cell 84, 309-320 (1996).
38. Moretti, A. et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127, 1151-1165 (2006).
39. Gyorffy, B. et al. An online survival analysis tool to rapidly assess the effect of 22, 277 genes on breast cancer prognosis using microarray data of 1, 809 patients. Breast Cancer Res. Treat. 123, 725-731 (2010).
40. Elangovan, S. et al. Molecular mechanism of SLC5A8 inactivation in breast cancer. Mol. Cell. Biol. 33, 3920-3935 (2013).
41. Elangovan, S. et al. The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival. Cancer Res. 74, 1166-1178 (2014).
42. Dontu, G. et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17, 1253-1270 (2003).
43. Pei, L. et al. Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia. Epigenetics 7, 567-578 (2012).
44. Ho, L. et al. esBAF facilitates pluripotency by conditioning the genome for LIF/STAT3 signalling and by regulating polycomb function. Nat. Cell. Biol. 13, 903-913 (2011).